Related Experiment Video
Updated: Dec 30, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation
Patrick A Gladding1, Malcolm Legget2, Diane Fatkin3
1North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand; Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand; Theranostics Laboratory, North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand.
Insights
Polygenic risk scores (PRS) improve risk prediction for coronary artery disease (CAD) and atrial fibrillation (AF) beyond traditional factors. Further research is needed to confirm the long-term benefits of PRS-guided management.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Epidemiology
Background:
- Coronary artery disease (CAD) and atrial fibrillation (AF) are leading causes of morbidity and mortality.
- Current risk factors are often identified late, after disease processes have begun.
- Understanding genetic contributions is crucial for early detection and prevention.
Purpose of the Study:
- To explore the role of genetic factors in the development of CAD and AF.
- To evaluate the utility of polygenic risk scores (PRS) in improving risk stratification for these complex cardiovascular diseases.
Main Methods:
- Review of genetic studies, including genome-wide association studies (GWAS), for CAD and AF.
- Discussion of the development and application of polygenic risk scores (PRS).
- Analysis of the incremental prognostic value of PRS in risk stratification algorithms.
Main Results:
- While rare variants can cause familial forms of CAD and AF, most cases are complex traits influenced by common variants.
- Genome-wide association studies have identified common variants associated with disease susceptibility, but individual variants have limited predictive power.
- Polygenic risk scores (PRS), aggregating effects of multiple common variants, have shown incremental prognostic information when added to clinical risk factors for CAD and AF.
Conclusions:
- Polygenic risk scores (PRS) offer a promising approach to enhance risk stratification for coronary artery disease (CAD) and atrial fibrillation (AF).
- Further evidence-based data are required to determine the long-term health and economic benefits of PRS-guided clinical management.
Abstract:
Coronary artery disease (CAD) and atrial fibrillation (AF) are two highly prevalent cardiovascular disorders that are associated with substantial morbidity and mortality. Conventional clinical risk factors for these disorders may not be identified prior to mid-adult life when pathophysiological processes are already established. A better understanding of the genetic underpinnings of disease should facilitate early detection of individuals at risk and preventative intervention. Single rare variants of large effect size that are causative for CAD, AF, or predisposing factors such as hypertension or hyperlipidaemia, may give rise to familial forms of disease. However, in most individuals, CAD and AF are complex traits in which combinations of genetic and acquired factors play a role. Common genetic variants that affect disease susceptibility have been identified by genome-wide association studies, but the predictive value of any single variant is limited. To address this issue, polygenic risk scores (PRS), comprised of suites of disease-associated common variants have been devised. In CAD and AF, incorporation of PRS into risk stratification algorithms has provided incremental prognostic information to clinical factors alone. The long-term health and economic benefits of PRS-guided clinical management remain to be determined however, and further evidence-based data are required.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Polygenic Traits
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology

